[Guidelines for diagnosis and treatment of heart failure].
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D015415:Biomarkers / Q000032:analysis; D002303:Cardiac Output, Low / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D002908:Chronic Disease; D017147:Defibrillators, Implantable; D003937:Diagnosis, Differential; D004232:Diuretics / Q000627:therapeutic use*; D004452:Echocardiography; D004562:Electrocardiography; D005080:Exercise Test; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006304:Health Status; D016027:Heart Transplantation; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D009204:Myocardial Revascularization; D010102:Oxygen Inhalation Therapy; D010347:Patient Care Planning; D017410:Practice Guidelines as Topic; D011315:Preventive Medicine; D012129:Respiratory Function Tests; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D004232:Diuretics; D005343:Fibrinolytic Agents; D000451:Mineralocorticoid Receptor Antagonists; D014665:Vasodilator Agents
Recommandations pour le diagnostic et le traitement de l'insuffisance cardiaque chronique. Diagnostic de l'insuffisance cardiaque chronique.